XNAS · INBS
-2.76% · -$0.0600 · Vol 22.8K
Market closed · last close 4:00 PM ET · price as of 19:24:12 ET
Intelligent Bio Solutions Inc. Common Stock

Intelligent Bio Solutions Inc. Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$2.11
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is INBS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for INBS are being assembled.
About Intelligent Bio Solutions Inc. Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2020
Employees
55
Country
US

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.18
Day high
$2.28
Day low
$2.14
Previous close
$2.17
52W high
$2.39
-11.69% from high
52W low
$2.11
0% of range
Market cap
$5.2M
EPS
$-5.4100
Shares out
2.4M
Volume
22.8K
VWAP
$2.18
Price history computed in-house
1W
-5.38%
1M
-8.66%
SMA 50 $2.26 · below
SMA 200 $2.26 · below
52W position 0%
Veridion warehouse edge

Warehouse intelligence for INBS.

Veridion Score
48
0: 941: 482: 393: 104: 825: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

INBS insider activity

Intelligent Bio Solutions Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for INBS.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

INBS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INBS in this window.
Lobbying spend

INBS lobbying filings, year to date.

Registered lobbying filings matched to Intelligent Bio Solutions Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for INBS in this window.
Latest news · INBS
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for INBS.
Options
Sovereign unlock shows live options positioning for INBS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.